Enzymotec to Report Second Quarter 2017 Financial Results
2017年7月26日 - 9:30PM
Enzymotec Ltd. (Nasdaq:ENZY) (“Enzymotec” or the “Company”), a
developer, manufacturer and marketer of innovative bio-active lipid
ingredients and medical foods, announced today that the Company
will release financial results for the second quarter ended June
30, 2017 on Wednesday, August 16, 2017, before the market opens.
Following the release, Erez Israeli, President and Chief Executive
Officer, and Oren Bryan, Vice President and Chief Financial
Officer, will host a conference call to review the financial
results.
The conference call is scheduled to begin at 8:30 am ET on
Wednesday, August 16, 2017. Participants should dial +1
877-359-9508 (United States) or +1 224-357-2393 (International)
with confirmation code #54908799 to access the live call. The call
will also be broadcast live over the Internet, hosted in the
Investors section of Enzymotec's website at
http://edge.media-server.com/m/p/fsb2hqfy, and will be archived
online within one hour of its completion.
About Enzymotec Ltd.
Enzymotec is a leading global supplier of
specialty lipid-based products and solutions. The Company develops,
manufactures and markets innovative bio-active lipid ingredients,
as well as final products, based on sophisticated processes and
technologies.
Company Contact
Enzymotec Ltd.
Oren Bryan
Chief Financial Officer
Phone: +972747177177
ir@enzymote.com
Investor Relations Contact (U.S.)
The Ruth Group
Tram Bui / Alexander Lobo
Phone: 646-536-7035 / 7037
tbui@theruthgroup.com
alobo@theruthgroup.com
ENZYMOTEC LTD. (NASDAQ:ENZY)
過去 株価チャート
から 8 2024 まで 9 2024
ENZYMOTEC LTD. (NASDAQ:ENZY)
過去 株価チャート
から 9 2023 まで 9 2024
Real-Time news about Enzymotec Ltd. - Ordinary Shares (delisted) (ナスダック市場): 0 recent articles
その他のニュース記事